Leveraging years of research accumulation and innovation capabilities, Genomeditech founded the reagent brand "Genoagent" in 2022, aiming to become the most trusted brand in the field of molecular biology reagents.
The most representative of these is Genomeditech's unique luciferase reporter gene series products, which offer high sensitivity and a low signal/background ratio, and have been widely applied and recognized in basic research and drug screening.
With a one-stop service, Genomeditech ushers in the era of premium enjoyment.
